Results 361 to 370 of about 137,029 (384)
Some of the next articles are maybe not open access.
Infliximab in Psoriatic Arthritis
The Journal of Rheumatology Supplement, 2012Tumor necrosis factor-α (TNF-α) plays a central role in the pathogenesis of psoriasis and psoriatic arthritis (PsA). Recently, 2 expert committees provided evidence-based recommendations for the treatment of PsA. Anti-TNF-α drugs are indicated in all forms of PsA resistant to traditional therapeutic approaches.
Olga Kaloudi+4 more
openaire +3 more sources
The Use of Infliximab in Dermatology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2007Infliximab is a chimeric monoclonal antibody that binds to tumor necrosis factor-alpha (TNF-α) which is major cytokine playing pivotal role in inflammatory diseases. Efficacy and safety of infliximab was studied in numerous inflammatory skin diseases where TNF-α is involved in pathogenesis especially in psoriasis and psoriatic arthritis.
Demirtaşoǧlu, Melda, FETİL, EMEL
openaire +6 more sources
Annals of Internal Medicine, 2018
Infliximab is an antitumor necrosis factor (TNF) monoclonal antibody approved for the treatment of Crohn disease (CD), ulcerative colitis, spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis.
A. Meyer+5 more
semanticscholar +1 more source
Infliximab is an antitumor necrosis factor (TNF) monoclonal antibody approved for the treatment of Crohn disease (CD), ulcerative colitis, spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis.
A. Meyer+5 more
semanticscholar +1 more source
Journal of Ocular Pharmacology and Therapeutics, 2011
Dear Editor: We read with interest the recent paper by Giansanti et al. on the intraocular safety of infliximab (Remicade ) in animal and cell culture models. Infliximab safety is an important factor as intraocular use of anti-Tumor Necrosis Factor (TNF)-a agents have been proposed as a potential therapeutic approach for patients with ocular ...
David G. Telander+2 more
openaire +3 more sources
Dear Editor: We read with interest the recent paper by Giansanti et al. on the intraocular safety of infliximab (Remicade ) in animal and cell culture models. Infliximab safety is an important factor as intraocular use of anti-Tumor Necrosis Factor (TNF)-a agents have been proposed as a potential therapeutic approach for patients with ocular ...
David G. Telander+2 more
openaire +3 more sources
Infliximab Treatment of Sarcoidosis
Annals of Pharmacotherapy, 2003OBJECTIVE: To determine whether there is sufficient evidence in the literature to support the use of infliximab in the treatment of sarcoidosis. DATA SOURCES AND SELECTION: Literature was accessed through MEDLINE (1966–August 2002), OVID (2001–January 2003), and bibliographic searches. Additional databases were also searched.
openaire +2 more sources
2014
Psoriasis and psoriatic arthritis are common chronic inflammatory disorders with substantial physical, financial and psychosocial burdens for patients. Biologic therapy for these conditions has been a major improvement in the therapeutic armamentarium. These drugs can maintain control of the disease, restore physical function and significantly improve ...
Robert E. Kalb, Cerrene Nicole Giordano
openaire +2 more sources
Psoriasis and psoriatic arthritis are common chronic inflammatory disorders with substantial physical, financial and psychosocial burdens for patients. Biologic therapy for these conditions has been a major improvement in the therapeutic armamentarium. These drugs can maintain control of the disease, restore physical function and significantly improve ...
Robert E. Kalb, Cerrene Nicole Giordano
openaire +2 more sources
Infliximab and Cogan’s syndrome
Clinical Otolaryngology, 2010E. Beccastrini+4 more
openaire +4 more sources